Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status

Archives of Neurology

Volumn 60, Issue 2, 2003, Pages 185-189

  Evans, Denis A ^a,c   Bennett, David A ^b   Wilson, Robert S ^b   Bienias, Julia L ^a   Morris, Martha Clare ^a   Scherr, Paul A ^d   Hebert, Liesi E ^a   Aggarwal, Neelum ^b   Beckett, Laurel A ^e   Joglekar, Rajiv ^c   Berry Kravis, Elizabeth ^c   Schneider, Julie ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; GENETIC RISK; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; URBAN POPULATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; EPIDEMIOLOGIC STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; RISK FACTORS; URBAN POPULATION;

EID: 0037318496     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.2.185     Document Type: Article

References (29)

1. Tang M-X, Stern Y, Marder K, et al. The APOE-e4 allele and the risk of Alzheimer disease among African Americans, whites, and hispanics. JAMA. 1998;79:751-755.
2. Schoenberg BS, Anderson DW, Haerer AV. Severe dementia: prevalence and clinical features in a biracial US population. Arch Neurol. 1985;42:740-743.
3. Hendrie HC, Osuntokun BO, Hall KS, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry. 1995;152:1485-1492.
4. Fillenbaum GG, Heyman A, Huber MS, et al. The prevalence and three-year incidence of dementia in older black and white community residents. J Clin Epidemiol. 1998;51:587-595.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science. 1993;261:921-923.
6. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.
7. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997;277: 822-824.
8. Sahota A, Yang M, Gao S, et al. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent. Ann Neurol. 1997;42:659-661.
9. Welsh KA, Butters N, Mohs RC, et al. CERAD part V: a normative study of the neuropsychological battery. Neurology. 1994;44:609-614.
10. Wechsler D. Wechsler Memory Scale-Revised Manual, New York, NY: Psychological Corp; 1987.
11. Albert MS, Smith LA, Scherr PA, et al. Use of brief cognitive tests to identify individuals in the community with clinically-diagnosed Alzheimer's disease. Int J Neurosci. 1991;57:167-178.
12. Smith A. Symbol Digit Modalities Test Manual-Revised. Los Angeles, Calif: Western Psychological Services; 1982.
13. Benton AL, Varney N, Hamsher KD. Visuospatial judgment: a clinical test. Arch Neurol. 1978;35:364-367.
14. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. Philadelphia, Pa: Lea & Febiger; 1972.
15. Ekstrom RB, French JW, Harman HH, Dermen D. Manual for Kit of Factor-Referenced Cognitive Tests. Princeton, NJ: Educational Testing Service; 1976.
16. Cooper JA, Sagar HJ. Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exper Neuropsychol. 1993;15:713-731.
17. Raven JC, Court JH, Raven J. Standard Progressive Matrices. Raven Manual. Oxford, England: Oxford Psychologists Press; 1992:section 3.
18. Nelson HE. National Adult Reading Test (NART) Test Manual. Windsor, England: NFER-Nelson Publishing Co Ltd; 1982.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
20. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
21. Hixson J, Vernier DO. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res. 1990;31:545-548.
22. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
23. Beckett LA, Scherr PA, Evans DA. Population prevalence estimates from complex samples. J Clin Epidemiol. 1992;45:393-402.
24. Beckett LA, Tancredi DJ. Parametric empirical Bayes estimates of disease prevalence using stratified samples from community populations. Statist Med. 2000;19:681-695.
25. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
26. SAS institute Inc. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc; 2000.
27. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun study. JAMA. 1997;277:813-817.
28. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995;273:1354-1359.
29. Fullerton SM, Clark AG, Weiss KM, et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67;881-900.